| Philip S Rogers, MD | |
|
415 Boulevard, Mountain Lakes, NJ 07046 | |
| (973) 334-7700 | |
| (973) 402-5847 |
| Full Name | Philip S Rogers |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 33 Years |
| Location | 415 Boulevard, Mountain Lakes, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174512776 | NPI | - | NPPES |
| 7755007 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MA067267 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Saint Clare's Hospital/ Denville Campus | Denville, NJ | Hospital |
| Hackettstown Medical Center | Hackettstown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiovascular Health Consultants, P.a. | 8325934706 | 106 |
| Practice Associates Medical Group | 5890703177 | 1116 |
News Archive
In a novel study comparing healthy cells from people in their 20s with cells from people in their 80s, researchers at the Johns Hopkins Kimmel Cancer Center say they have documented that cell division rates appear to consistently and markedly slow down in humans at older ages.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today presented preclinical and clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor at the 15th Congress of the European Hematology Association in Barcelona, Spain.
A prospective cohort study of 31,783 American women has found no significant association between levels of physical activity and colon cancer incidence.
Pathbreaking developments in tissue engineering and regenerative therapies are facilitating the design and growth of new organs in labs using biopolymer scaffolds and matrices. Analysis of potential markets for tissue engineering reveals that basic problems such as vascularity must be solved before such implants can gain acceptance as standard treatment methods.
Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.
› Verified 9 days ago
| Entity Name | Cardiovascular Health Consultants, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437291739 PECOS PAC ID: 8325934706 Enrollment ID: O20040224000028 |
News Archive
In a novel study comparing healthy cells from people in their 20s with cells from people in their 80s, researchers at the Johns Hopkins Kimmel Cancer Center say they have documented that cell division rates appear to consistently and markedly slow down in humans at older ages.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today presented preclinical and clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor at the 15th Congress of the European Hematology Association in Barcelona, Spain.
A prospective cohort study of 31,783 American women has found no significant association between levels of physical activity and colon cancer incidence.
Pathbreaking developments in tissue engineering and regenerative therapies are facilitating the design and growth of new organs in labs using biopolymer scaffolds and matrices. Analysis of potential markets for tissue engineering reveals that basic problems such as vascularity must be solved before such implants can gain acceptance as standard treatment methods.
Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.
› Verified 9 days ago
| Entity Name | Practice Associates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427016385 PECOS PAC ID: 5890703177 Enrollment ID: O20060330000690 |
News Archive
In a novel study comparing healthy cells from people in their 20s with cells from people in their 80s, researchers at the Johns Hopkins Kimmel Cancer Center say they have documented that cell division rates appear to consistently and markedly slow down in humans at older ages.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today presented preclinical and clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor at the 15th Congress of the European Hematology Association in Barcelona, Spain.
A prospective cohort study of 31,783 American women has found no significant association between levels of physical activity and colon cancer incidence.
Pathbreaking developments in tissue engineering and regenerative therapies are facilitating the design and growth of new organs in labs using biopolymer scaffolds and matrices. Analysis of potential markets for tissue engineering reveals that basic problems such as vascularity must be solved before such implants can gain acceptance as standard treatment methods.
Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip S Rogers, MD Po Box 416457, Boston, MA 02241-6457 Ph: (844) 362-1735 | Philip S Rogers, MD 415 Boulevard, Mountain Lakes, NJ 07046 Ph: (973) 334-7700 |
News Archive
In a novel study comparing healthy cells from people in their 20s with cells from people in their 80s, researchers at the Johns Hopkins Kimmel Cancer Center say they have documented that cell division rates appear to consistently and markedly slow down in humans at older ages.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today presented preclinical and clinical data on CAL-101, the Company's oral, delta selective PI3K inhibitor at the 15th Congress of the European Hematology Association in Barcelona, Spain.
A prospective cohort study of 31,783 American women has found no significant association between levels of physical activity and colon cancer incidence.
Pathbreaking developments in tissue engineering and regenerative therapies are facilitating the design and growth of new organs in labs using biopolymer scaffolds and matrices. Analysis of potential markets for tissue engineering reveals that basic problems such as vascularity must be solved before such implants can gain acceptance as standard treatment methods.
Changing the hospital orders for women who have just delivered a child led to a 69% increase in the new mothers' pertussis vaccination rate, providing protection for themselves and their newborns against the disease, commonly known as whooping cough, according to a study in the March issue of the American Journal of Obstetrics & Gynecology.
› Verified 9 days ago
Christopher Michael Tully, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701 Fax: 973-316-1708 | |
Ronald D Massari, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 356 Route 46 E, Mountain Lakes, NJ 07046 Phone: 973-586-3400 Fax: 973-586-1916 | |
Keith S Leibowitz, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-402-5847 | |
Paul D Derenzi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-402-5847 | |
Hyeun S Park, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 415 Boulevard, Mountain Lakes, NJ 07046 Phone: 973-334-7700 Fax: 973-334-7116 | |
Dr. Muhammad R. Abbasi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Route 46 W, Mountain Lakes, NJ 07046 Phone: 973-316-1701 Fax: 973-316-1708 |